Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...

Could the expectation that men need to be "manly" end up damaging their hearts? Researchers reveal a concerning trend among ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates ...

The Lagos State Government has launched a state-wide screening and public enlightenment campaign on hypertension and diabetes.

Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with ...

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive ...

Its growth is attributed to technological advancements and developments. The Japan diabetes device market is projected to ...

People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

The lives of Americans could be dramatically improved, and in thousands of cases even saved, by increasing access to ...